Cystic disease/congenital anomalies
Reviewers: Elliot Weisenberg, M.D. (see Reviewers page)
Revised: 25 August 2011, last major update August 2011
Copyright: (c) 2003-2011, PathologyOutlines.com, Inc.
● Complication of mechanical ventilation and oxygen therapy for treatment of neonatal respiratory distress syndrome
● Infants almost always < 1200 gram birth weight and < 30 weeks gestation
● Definition: requirement for supplemental oxygen for longer than 28 days of age, and a post-menstrual age of at least 36 weeks (eMedicine)
● Due to decreased alveolar septation and capillary derangement, secondary to arrested septation of lungs, due to therapy in the saccular stage of lung development
● Free radicals generated by oxygen therapy and inflammatory cytokines play a role in pathogenesis
● Incidence has fallen with use of surfactant therapy in premature infants for neonatal respiratory distress syndrome (Semin Perinatol 2006;30:171)
● Respiratory distress continues for months
● Patients have limited pulmonary reserve, develop repeated infections, often have pulmonary hypertension and develop cor pulmonale
● Bronchiolar and interstitial fibrosis, compensatory emphysema of less damaged acini
● Inadequate alveolar development causes fewer but larger alveoli
Respiratory distress syndrome & bronchopulmonary dysplasia
● Semin Perinatol 2006;30:164
End of Lung-nontumor > Cystic disease/congenital anomalies > Bronchopulmonary dysplasia
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).